Automated dosimetry
Accurate dosimetry is a cornerstone of preclinical research, particularly in the development of radioligand therapies. preclinIQ provides automated dosimetric analysis directly from AI-generated segmentations, eliminating the need for manual organ delineation.
Our pipeline quantifies organ-level activity from PET or SPECT data, delivering standardized uptake values (SUVs) and dose estimates with high correspondence to expert annotations. This ensures that preclinical biodistribution and therapy studies can be performed with both speed and scientific rigor.
Key advantages include:
- Reliability: validated against manual annotations with errors typically below 10% in key organs
- Scalability: supports high-throughput dosimetry across large cohorts
- Consistency: reproducible organ definitions remove operator bias
- Integration: dosimetry results are returned in the .csv format (Comma-separated values) and can be reviewed in existing analysis software
By automating dosimetry, preclinIQ enables researchers to accelerate drug development, reduce labor costs, and ensure robust, reproducible quantification for every study.